Ligand Pharmaceuticals Incorporated (LGND)
USD 96.67
(-2.76%)
USD 96.67
(-2.76%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 131.31 Million | 196.24 Million | 277.13 Million | 186.41 Million | 120.28 Million | 251.45 Million |
| Cost of Revenue | 11.56 Million | 52.82 Million | 62.17 Million | 30.41 Million | 11.34 Million | 6.33 Million |
| Gross Profit | 119.75 Million | 143.41 Million | 214.95 Million | 156 Million | 108.93 Million | 245.11 Million |
| Operating Expenses | 84.32 Million | 140.38 Million | 136.06 Million | 147.26 Million | 114.65 Million | 81.38 Million |
| Selling, General and Administrative Expenses | 52.79 Million | 70.06 Million | 57.48 Million | 64.43 Million | 41.88 Million | 37.73 Million |
| Research and Development Expenses | 24.53 Million | 36.08 Million | 69.01 Million | 59.39 Million | 55.9 Million | 27.86 Million |
| Other Expenses | 6.99 Million | 34.23 Million | 9.56 Million | 23.44 Million | 16.86 Million | 15.79 Million |
| Cost and Expenses | 119.37 Million | 193.2 Million | 198.23 Million | 177.68 Million | 126 Million | 87.72 Million |
| Operating Income | 11.94 Million | -25.5 Million | 78.89 Million | 8.55 Million | -5.72 Million | 163.72 Million |
| Interest Expense | 656 Thousand | 1.79 Million | 18.74 Million | 27.42 Million | 35.74 Million | 48.27 Million |
| Income Tax Expense | 9.84 Million | 41.23 Million | -10.28 Million | -7.55 Million | 167.33 Million | 30 Million |
| Earnings before Tax | 63.66 Million | 36.01 Million | 47.29 Million | -10.53 Million | 796.63 Million | 173.33 Million |
| Net Income | 52.15 Million | -5.21 Million | 57.13 Million | -2.98 Million | 629.3 Million | 143.32 Million |
| Earnings Per Share Basic | 3.02 | -0.31 | 3.44 | -0.18 | 33.13 | 5.96 |
| Earnings Per Share Diluted | 2.94 | -0.31 | 3.31 | -0.18 | 31.85 | 5.96 |
| Weighted Average Shares Outstanding | 17.29 Million | 16.86 Million | 16.62 Million | 16.18 Million | 18.99 Million | 24.04 Million |
| Weighted Average Shares Outstanding (Diluted) | 17.75 Million | 16.86 Million | 17.24 Million | 16.18 Million | 19.75 Million | 24.06 Million |
| Gross Margin | 0.91 | 0.73 | 0.78 | 0.84 | 0.91 | 0.97 |
| EBIT Margin | 0.77 | 0.04 | 0.42 | 0.17 | -6.69 | 0.71 |
| Profit Margin | 0.40 | -0.03 | 0.21 | -0.02 | 5.23 | 0.57 |
| EBITDA | 101.72 Million | 54.4 Million | 133.16 Million | 69.05 Million | 38.01 Million | 238.29 Million |
| Earnings Before Tax Margin | 0.09 | -0.13 | 0.28 | 0.05 | -0.05 | 0.65 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 41.53 Million | 30.97 Million | 131.31 Million | 28.1 Million | 32.86 Million | 26.36 Million |
| Cost of Revenue | 11.16 Million | 11.06 Million | 11.56 Million | 1.66 Million | 3.48 Million | 1.66 Million |
| Gross Profit | 30.36 Million | 19.91 Million | 119.75 Million | 26.43 Million | 29.38 Million | 24.69 Million |
| Operating Expenses | 22.97 Million | 16.92 Million | 109.93 Million | 29.79 Million | 28.42 Million | 26.68 Million |
| Selling, General and Administrative Expenses | 19.12 Million | 10.95 Million | - | 15.99 Million | 14.65 Million | 11.28 Million |
| Research and Development Expenses | 5.35 Million | 5.97 Million | - | 5.48 Million | 5.53 Million | 6.85 Million |
| Other Expenses | 1.5 Million | -2.38 Million | -32.6 Million | -8.31 Million | -4.3 Million | -873 Thousand |
| Cost and Expenses | 34.14 Million | 27.99 Million | 121.49 Million | 31.45 Million | 31.91 Million | 28.34 Million |
| Operating Income | 7.39 Million | 2.98 Million | 9.82 Million | -3.35 Million | -122 Thousand | -1.98 Million |
| Interest Expense | 1.26 Million | 141 Thousand | 656 Thousand | 131 Thousand | -1000.00 | 2.03 Million |
| Income Tax Expense | -13.47 Million | 27.3 Million | 9.84 Million | -1.09 Million | -2.55 Million | 881 Thousand |
| Earnings before Tax | -65.39 Million | 113.44 Million | 63.66 Million | 17.09 Million | -15.34 Million | 3.17 Million |
| Net Income | -51.91 Million | 86.13 Million | 52.15 Million | 18.18 Million | -12.79 Million | 2.29 Million |
| Earnings Per Share Basic | -2.88 | 4.86 | - | 1.04 | -0.74 | 0.13 |
| Earnings Per Share Diluted | -2.88 | 4.75 | - | 1.03 | -0.74 | 0.13 |
| Weighted Average Shares Outstanding | 18.02 Million | 17.73 Million | 17.29 Million | 17.46 Million | 17.38 Million | 17.27 Million |
| Weighted Average Shares Outstanding (Diluted) | 18.02 Million | 18.12 Million | 17.75 Million | 17.67 Million | 17.38 Million | 17.73 Million |
| Gross Margin | 0.73 | 0.64 | 0.91 | 0.94 | 0.89 | 0.94 |
| EBIT Margin | 0.40 | 0.39 | - | 0.35 | 0.71 | 0.10 |
| Profit Margin | -1.25 | 2.78 | 0.40 | 0.65 | -0.39 | 0.09 |
| EBITDA | 16.74 Million | 12.23 Million | - | 9.87 Million | 23.45 Million | 2.56 Million |
| Earnings Before Tax Margin | 0.18 | 0.10 | 0.07 | -0.12 | -0.00 | -0.08 |
SFIIF
AKA
2159
ESLT
LTM
WMT